Research
Hormonal
Exercise improves sleep quality indirectly by enhancing mood and reducing depressive symptoms, potentially through mechanisms involving Brain-Derived Neurotrophic Factor (BDNF) and monoamine activation.
If you struggle with sleep due to low mood or depression, exercise is a potent tool. It not only improves physical health but also normalizes neurotrophic factors like BDNF, which can alleviate depressive symptoms and indirectly restore healthy sleep patterns.
ModerateSupportsMEDIUM confidence
it is plausible that the effects of chronic exercise in improving sleep quality could be a relevant mechanism [for depression].
Why this rating
The paper cites therapeutic effects of exercise on depression and BDNF normalization, but states the direct link to sleep quality via BDNF is not yet established.
Source
Exercise Effects on Sleep Physiology
Sunao Uchida et al. · Frontiers in Neurology · 2012
DOI 10.3389/fneur.2012.00048
narrative_reviewCited 266×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Chronic exercise significantly improves sleep quality by increasing total sleep time and reducing time awake after sleep onset, whereas acute exercise effects on slow-wave sleep are inconsistent and depend heavily on timing and intensity.Good
- Acute exercise increases body temperature, which may promote Slow Wave Sleep (SWS) by facilitating the subsequent drop in core body temperature required for sleep onset, although empirical evidence remains inconsistent.Limited
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →